Alternate-Day Buprenorphine Administration. Phase VII - 8

Alternate-Day Buprenorphine Administration. Phase VII

The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects under open dosing conditions.

Please contact site for information.